[Therapeutic results: tacrine].
Tacrine is the first drug having been demonstrated as effective for the treatment of mild and moderate forms of Alzheimer's disease. It works as a potent centrally active inhibitor of acetylcholinesterase and therefore has cholinomimetic properties. The authors evaluate the costs/benefits ratio of this drug taking into account clinical and economical data.